Genome Technologies

Platform Leader
Dr. John McPherson
OICR

The Genome Technologies Platform uses cancer genome sequencing and other high-throughput techniques to identify genes critical to the development of cancer and anomalies in the genomic profile of tumours. Genetic mutations involved in pancreatic cancer are being mapped as part of the platform’s role in the International Cancer Genome Consortium. The Platform also fosters a relationship with The Broad Institute of Harvard and MIT to collaborate on RNAi technology.